Cosmos Health regains Nasdaq minimum bid price compliance

Cosmos Health Inc.

Received Nasdaq notification on July 19, 2024 that it regained compliance with Listing Rule 5550(a)(2).
Closing bid price was $1.00 or greater for ten consecutive business days from July 5 to July 18, 2024.
CEO Greg Siokas stated compliance was achieved organically without a reverse stock split.
Nasdaq has closed the matter; no further action required.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.